Considerations for Statin Therapy in Patients with COVID-19.Pharmacotherapy. 2020 05; 40(5):484-486.P
Citation
Dashti-Khavidaki, Simin, and Hossein Khalili. "Considerations for Statin Therapy in Patients With COVID-19." Pharmacotherapy, vol. 40, no. 5, 2020, pp. 484-486.
Dashti-Khavidaki S, Khalili H. Considerations for Statin Therapy in Patients with COVID-19. Pharmacotherapy. 2020;40(5):484-486.
Dashti-Khavidaki, S., & Khalili, H. (2020). Considerations for Statin Therapy in Patients with COVID-19. Pharmacotherapy, 40(5), 484-486. https://doi.org/10.1002/phar.2397
Dashti-Khavidaki S, Khalili H. Considerations for Statin Therapy in Patients With COVID-19. Pharmacotherapy. 2020;40(5):484-486. PubMed PMID: 32267560.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Considerations for Statin Therapy in Patients with COVID-19.
AU - Dashti-Khavidaki,Simin,
AU - Khalili,Hossein,
Y1 - 2020/05/04/
PY - 2020/03/30/received
PY - 2020/03/31/accepted
PY - 2020/4/9/pubmed
PY - 2020/5/21/medline
PY - 2020/4/9/entrez
KW - COVID-19
KW - HMG-CoA reductase inhibitor
KW - SARS-CoV
KW - coronavirus infection
KW - statin
SP - 484
EP - 486
JF - Pharmacotherapy
JO - Pharmacotherapy
VL - 40
IS - 5
SN - 1875-9114
UR - https://www.unboundmedicine.com/medline/citation/32267560/Considerations_for_Statin_Therapy_in_Patients_with_COVID_19_
DB - PRIME
DP - Unbound Medicine
ER -
Try the Free App:
